Addressing the key issues in the public debate about prescription drugs, this book
establishes an analytical framework for the development of regulatory policy in this area. A …

Since the launch of the Europe against Cancer (EAC) programme in 1987, diverse tobacco
control measures have been introduced: a ban on tobacco advertising on television …

On assuming power in 1997,(New) Labour promised more accountability in the policy-
making arena as part of their 'modernising agenda'. Evidence-based policy making, the …

This article reports on a study which aimed to explore the extent to which drug policy making
in Ireland might be deemed to be a rational, evidence-based process. The research was …

Our objective was to examine conflicts of interest between the UK's health-focused All-Party
Parliamentary Groups (APPGs) and the pharmaceutical industry between 2012 and 2018 …

Across the world medicines are the ubiquitous technology in the diagnosis, treatment and
prevention of disease. Pharmaceutical policy, as part of national health care policy, is …

As evidence mounts that corporate actor engagement in United Nations (UN) policy-making
processes leads to weaker and shallower public health commitments, greater attention is …

This paper, prepared by the European Public Health Alliance, explores the future of EC
activities in the health area, and how Article 129, the new public health chapter in the …

Informed by recent sociological debates on pharmaceuticalisation, this article examines the
evolution of the current EU legal proposal on prescription drug information to patients, as …

ABSTRACT In December 2012 the European Union (EU) Commission announced that it will
propose a revision of the 2001 Tobacco Products Directive (TPD). This paper traces the …